GVR Report cover Biobanks Market Size, Share & Trends Report

Biobanks Market Size, Share & Trends Analysis Report By Product (LIMS, Biobanking Equipment), Biospecimen Type (Organs, Stem Cells), Biobank Type (Real, Virtual), Service, Application, Segment Forecasts, 2024 - 2030

  • Report ID: GVR-2-68038-564-9
  • Number of Report Pages: 185
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Biobanks Market Size & Trends

The global biobank market size was estimated at USD 76.74 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2030. High investments in the R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, are some of the driving factors. Moreover, the onset of COVID-19 has put biobanks at the forefront of the pandemic control measures, resulting in the organic revenue growth of the market. The COVID-19 outbreak had a major influence on the biobanking industry. Biobanking is important for the diagnosis & production of medicines for a variety of disorders. International initiatives to produce vaccines and other medicines to prevent the spread of the virus have been urgently needed.

U.K. Biobank market size and growth rate, 2024 - 2030

The collection, processing, and analysis of patient samples are at the frontline of the COVID-19 crisis. For example, the Health Minister announced EUR 2 million in financing for the National Irish COVID-19 Biobank (NICB) in a July 2021 update from the Government of Ireland. The NICB has become a critical part of Ireland’s COVID-19 pandemic response. According to a February 2021 release, the Sample Collection Database was designed by the SciLifeLab Data Centre in partnership with Biobank Sweden and the research area ‘Biobanks for COVID-19’ of the SciLifeLab & KAW National COVID-19 research program.

Furthermore, Tulane University announced a new COVID-19 biobank containing blood & cell samples from survivors in July 2021 to aid researchers in determining why some people heal rapidly while others have long-term effects. As a result, such activities show that the outbreak of the pandemic boosted the demand for biobank services, benefiting the global economy.

The increasing popularity of precision/personalized medicine and genetic testing has been a key driver of the market. Biobanks have been playing a significant role in biomedical research. Over the past few decades, there have been several advances in platforms and tools used in genetic studies. This has led to an increase in demand for biospecimens from clinical labs to develop assays for genetic testing. Collaborations between private and public institutions in biobanking have played a crucial role in market progression.

Digitalization, precision medicine, and virtualization are rapidly changing the biobanking industry through the development of novel methods and concepts of synergies initiated by public and private organizations. Companies across all fields are partnering with biobanks, which accelerates the market revenue. For instance, in October 2023, UK Biobank partnered with several philanthropists. Through this partnership, UK Biobank will access USD 34.5 million in funding.

An exponential increase in the number of global cases has rendered the significance of biobanks in containing the spread of the virus. High-quality COVID-19 specimens are required and helpful for both research and diagnostic purposes, and biobanks are considered vital repositories for these samples. Thus, biobanks are gaining ground to support clinical research and drug discovery processes to combat this global disaster.

Developing countries from the Middle East region are investing in biobanks to advance the medical research domain in the country. For instance, in September 2023, the Crown Prince of Abu Dhabi announced the launch of a biobank to support the requirement of personalized medicine through advanced treatments that utilize human tissues and stem cells in medical research. This research will help treat over 80 diseases and immune system issues. Moreover, it strengthens the position of the UAE in the global biobanks market.

Market Concentration & Characteristics

Market growth stage is high, and pace of the market growth is accelerating. The biobanks market has witnessed significant innovation, from traditional sample storage to incorporating advanced data management, analytics tools, and automation. Integration of omics technologies, such as genomics, and increased collaboration globally has further enhanced research capabilities. These developments accelerate biomedical research and contribute to the evolution of personalized medicine.

Biobank Market Concentration & Characteristics

The market is also characterized by a high level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to gain access to new biobank technologies and talent, need to consolidate in a rapidly growing market, and its usage in research and development.

The biobanks market is also subject to increasing regulatory scrutiny. These regulations dictate the responsible collection, storage, and use of biological samples, emphasizing informed consent, privacy protection, and data security. Compliance is crucial for ensuring the reliability of stored samples, facilitating international collaboration, and addressing emerging ethical considerations related to advancements in technologies such as genomics and data analytics.

Product expansion in the market for biobank involves strategic initiatives to introduce new services and offerings. The key players focus on diversifying sample collections, implementing advanced data management systems, providing specialized services, creating collaborative platforms, integrating omics technologies, adopting automation, and establishing global partnerships.

In the biobanks market, regional expansion involves biobanking entities strategically broadening their activities beyond current geographic boundaries. Hence, key players undertake several business initiatives, such as geographical expansion, partnerships, and collaboration, to gain a regional customer base.

Product Insights

On the basis of products, the global market has been further sub-segmented into biobanking equipment, biobanking consumables, and Laboratory Information Management Systems (LIMS). The biobanking equipment segment dominated the market and accounted for the largest revenue share of 77.0% in 2023 owing to a rapid increase in the number of new biobanks and the high cost of initial equipment installation. A wide range of equipment is offered to cater to different biobanking processes, such as sample preparation, collection, processing, storage, and shipment.

The Laboratory Information Management Systems (LIMS) segment is anticipated to grow at the fastest CAGR of 10.5% during the forecast period. Biobanks need to follow well-designed & documented procedures to provide high-quality samples. Biobank services are accessed based on the number of valuable samples and the chain of custody of these samples, which includes non-identifiable subjects. Without reliable and accurate data, samples have no true value in research. This makes management of sample information a significant aspect in biobanking. In February 2023, UK Biobank announced that it made a public dataset from 45,000 Magnetic Resonance Imaging (MRI) scans.

Service Insights

On the basis of services, the global market has been further sub-segmented into biobanking & repository, lab processing, qualification/validation, cold chain logistics, and other services. The biobanking and repository services segment dominated the market and accounted for the largest share of the global revenue in 2023. This is owing to the higher market penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research. The expansion of biobanking services from academic research to include clinical enterprises and government initiatives, as well as highly networked and open-ended ventures, has supported the segment.

The qualification/validation segment is also expected to witness significant growth in the near future and is estimated to account for the second-largest revenue share by 2030. Validation services are necessary when new equipment is installed, when units are relocated, before initiating a major project, cold chain logistics, and sample storage & extraction. Validation services should be designed and executed in such a way that they comply with the U.S. FDA regulations and quality standards established by governing bodies. Biobanks provide services that are in line with regulatory requirements. Standard, high-quality services are offered for collection, processing, storage, and transportation of samples. Validation services can help qualify a shipper, aid in the validation of a process, evaluate testing equipment to make sure that integrity of biological sample is maintained throughout the chain of processes, and facilitate effective management of biological samples.

Biospecimen Type Insights

On the basis of biospecimen types, the global market has been categorized into human tissues, organs, stem cells, and other biospecimen. The human tissues segment dominated the market and accounted for the largest revenue share in 2023. This is owing to a large number of biobanks with facilities to store tissues, easy availability of tissue samples, and availability of advanced technology for storage and retrieval of banked tissues. Growing investment in disease-specific R&D is anticipated to foster the demand for diseased tissue samples, such as lymphoma, myeloma, ovarian leukemia, brain, prostate, colorectal carcinoma breast, and lung tissues for oncology studies.

In the effort to advance the research on COVID-19 and improve its diagnosis and treatment, the stem cells segment is expected to witness fastest growth for the forecast period. The number of established stem cell biobanks has been increasing rapidly worldwide. Promising applications of stem cells in regenerative medicine, cell therapy, developmental biology, toxicology, and drug development can be attributed to the rapid increase in the number of stem cell banks. Preservation of cellular characteristics, preventing deterioration & contamination, use in basic & translation research, and potential and current use in clinical applications are factors that significantly contributed to the adoption of stem cell banking.

Biobanks Type Insights

On the basis of biobank types, the global market has been further bifurcated into physical/real biobanks and virtual biobanks. The physical/real biobanks segment dominated the market in 2023 and accounted for the largest revenue. These biobanks have a well-established network, thereby holding a high revenue share. Rapid progress in the fields of bioinformatics analysis and precision medicine can be attributed to this change in the operating strategy of the biobanks. A large collection of tissue samples from pathological labs, clinical trials, and research projects over the years contributes to the largest share of tissue banks in 2023.

However, the virtual biobanks segment is expected to witness the fastest growth for the forecast period. Virtual biobanks have emerged to address the problems related to the accessibility of biospecimen. Tissue Solutions (Scotland) and Human Focused Testing (Little port) are examples of organizations whose core operating activity involves procurement and distribution of samples as per requirement. The potential to fulfill the need for biospecimens and the ability to trace and obtain rare samples improves with virtual biobanking. Also, easy accessibility associated with virtual biobanks contributes to the lucrative growth of the segment.

Application Insights

On the basis of applications, the market has been further categorized into therapeutics, drug discovery & clinical research, clinical diagnostics, and other applications. In 2023, the therapeutics application segment dominated the market with the largest revenue share. This can be attributed to the ever-increasing demand for advanced therapies for the treatment of chronic diseases. Furthermore, the exponential increase in the number of COVID-19 cases across the globe has resulted in an increasing need for development of novel viral therapeutics. Various studies are being conducted to accelerate research in this field.

Global Biobank market share and size, 2023

For instance, Mayo Clinic has initiated an observational study for prospectively collecting research biospecimen and clinical data from COVID-19 patients, to enable high-quality research, thereby driving the segment growth. On the other hand, the clinical diagnostics segment is anticipated to witness significant growth over the forecast period. Comparison of biospecimen obtained from healthy and diseased individuals advances the clinical diagnosis process, especially for cancer. It helps investigate the treatment response of the patient and identify a new tumor in a patient with a history of cancer.

Regional Insights

Europe accounted for the maximum revenue share of 38.4 % in 2023 owing to the continuous investment in the collection, establishment, and processing of large-scale datasets. Furthermore, countries like UK, Germany, and France among others are contributing to the region's market growth by investing in biobank solutions. For instance, in June 2023, The Medicines and Healthcare products Regulatory Agency (MHRA) collaborated with Genomics England to launch its genetic biobank.

Biobank Market Trends, by Region, 2024 - 2030

However, the Asia Pacific region is expected to witness the fastest CAGR for the forecast period. The growth can be attributed to the investment of developing economies like India, China, and Japan. These countries are actively engaged in developing the biobanks market by undertaking several business initiatives to strengthen their market position. For instance, in November 2023, AIG Hospital launched its first biobank in India’s southern region. The biobank will collect over one lakh tissue and blood samples for the upcoming decade.

  • The presence of private biobanks in India propels biobank services in the country. For instance, biobanks such as the International Institute of Innovation and Technology Bio-repository (i3tBR), JIPMER PBMC Puducherry, MCRI, and National Liver Disease Biobank, represent state-of-the-art biobanks in the country.

  • The biobank in Australia promotes the adoption of research activities and is funded by the Australian Department of Health. The country also has the presence of several other biobanks, including the Australian Breast Cancer Tissue Bank, Human Studies Unit - Institute for Molecular Bioscience Saint Lucia, South Australian Cancer Research Biobank, and Victorian Cancer Biobank. Moreover, the country has developed much of the infrastructure necessary for supporting the development of large-scale population-based biobanks.

Key Companies & Market Share Insights

Some of the key players operating in the market are adopting various organic & inorganic strategies such as collaborations with biobanking service providers and technological innovation to advance their product offerings in the biobanking industry. 

Key Biobanks Companies:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Qiagen
  • Hamilton Company
  • Tecan Trading AG
  • Danaher Corporation
  • Becton, Dickinson, and Company (BD)
  • Biocision, LLC.
  • Taylor-Wharton
  • Charles River Laboratories
  • Lonza
  • Stemcell Technologies
  • Biovault Family
  • Promocell Gmbh
  • Precision Cellular Storage Ltd. (Virgin Health Bank)

Recent Developments

  • In October 2023, AstraZeneca research announced unique relationships between rare changes in plasma proteins and genes that could enhance drug discovery with data from more than 50,000 UK Biobank participants.

  • Similarly, in January 2023, Hamad Medical Corporation, in collaboration with Qatar BioBank, launched a Tissue Biobank Service in Qatar. This biobank will focus on collecting samples and finding new potential treatments for heart diseases & cancer.

  • In January 2023, Quibim and European Commission launched European Commission’s European Federation for Cancer Images (EUCAIM) biobank. This biobank will focus on developing treatments for cancers along with early detection techniques.

  • In December 2023, Charles River Laboratories International, Inc. announced an agreement with CELLphenomics to expand 3D In Vitro Services for drug screening of cancer therapy. CELLphenomics biobank has over 500 in vitro models from around 20 tumor entities. It offers one of the largest complex in vitro models of rare and ultra-rare tumors like thymomas or sarcomas.

  • . In July 2023, Tecan announced the launch of Phase Separator. It has several applications in biobanking and liquid biopsy and is expected to benefit proteomics, genomics and across numerous disease areas, from neurodegenerative and oncology diseases to metabolic disorders.

  • In January 2023, Thermo Fisher Scientific, Inc. announced its participation as a founding sponsor of Momentum Labs, a new biotech hub located in Alachua, Florida. This collaboration aims to support the growth of innovative biotech startups and drive advancements in the industry. With Thermo Fisher's expertise in the life sciences and its commitment to innovation, the company is well-positioned to play a significant role in the success of Momentum Labs and the companies it supports. The establishment of this hub is expected to have a positive impact on the local economy and further solidify Florida's position as a hub for biotech innovation.

  • In February 2022, Hamilton company expanded its range of VersoQ series of storage systems at a debut at SLAS 2022 conference. This would increase the company’s product offerings in biobanking.

Biobanks Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 82.65 billion

Revenue forecast in 2030

USD 136.91 billion

Growth rate

CAGR of 8.8% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, service, biospecimen type, biobanks type, application, ownership, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Germany; U.K.; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Thermo Fisher Scientific Inc.; Merck KGaA; Qiagen; Hamilton Company; Tecan Trading AG; Danaher Corporation; Becton, Dickinson, and Company (BD); Biocision, LLC.; Taylor-Wharton; Charles River Laboratories; Lonza; Stemcell Technologies; Biovault Family; Promocell Gmbh, Precision Cellular Storage Ltd. (Virgin Health Bank)

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Biobank Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global biobanks market report based on product, service, biospecimen type, biobanks type, application, ownership, end-use, and region:

  • Product Outlook (Revenue, USD Billion, 2018 - 2030)

    • Biobanking Equipment

      • Temperature Control Systems

        • Freezers & Refrigerators

        • Cryogenic Storage Systems

        • Thawing Equipment

      • Incubators & Centrifuges

      • Alarms & Monitoring Systems

      • Accessories & Other Equipment

    • Biobanking Consumables

    • Laboratory Information Management Systems

  • Service Outlook (Revenue, USD Billion, 2018 - 2030)

    • Biobanking & Repository

    • Lab Processing

    • Qualification/ Validation

    • Cold Chain Logistics

    • Other Services

  • Biospecimen Type Outlook (Revenue, USD Billion, 2018 - 2030)

    • Human Tissues

    • Human Organs

    • Stem Cells

      • Adult Stem Cells

      • Embryonic Stem Cells

      • IPS Cells

      • Other Stem Cells

    • Other Biospecimens

  • Biobanks Type Outlook (Revenue, USD Billion, 2018 - 2030)

    • Physical/Real Biobanks

      • Tissue Biobanks

      • Population Based Biobanks

      • Genetic (DNA/RNA)

      • Disease Based Biobanks

    • Virtual Biobanks

  • Application Outlook (Revenue, USD Billion, 2018 - 2030)

    • Therapeutics

    • Drug Discovery & Clinical Research

    • Clinical Diagnostics

    • Other Applications

  • Ownership Outlook (Revenue, USD Billion, 2018 - 2030)

    • University Owned

    • National/Regional Agencies Owned

    • Non-profit Organizations Owned

    • Private Organization Owned

  • End-use Outlook (Revenue, USD Billion, 2018 - 2030)

    • Pharmaceutical & Biotechnology Companies

    • CROs & CMOs

    • Academic & Research Institutes

    • Hospitals

  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

      • France

      • Spain

      • Italy

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Biobanks Market: Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Service
                        1.2.3. Biospecimen Type
                        1.2.4. Biobanks Type
                        1.2.5. Application
                        1.2.6. Ownership
                        1.2.7. End-use
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Biobanks Market: Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Biobanks Market: Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Continuous increase in COVID-19 cases along with capacity expansion
                            3.2.1.2. Increased focus on precision medicine and genetic testing
                            3.2.1.3. Changes in biobanking operations
                            3.2.1.4. Increase in the number of clinical trials globally
                            3.2.1.5. Growing industry and research collaborations
                            3.2.1.6. Technology advancement and automation
                        3.2.2. Market restraint analysis
                            3.2.2.1. Disruptions in supply chain management due to COVID-19
                            3.2.2.2. Challenges in sharing biobanking data & limited access to biospecimens
                            3.2.2.3. Sustainability challenges for biobanks
                            3.2.2.4. Other challenges in biobanking specimens for research
                    3.3. Biobanks Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. Biobanks Market: Product Estimates & Trend Analysis
                    4.1. Product Market Share, 2023 & 2030
                    4.2. Global Biobanks Market by Product Outlook
                    4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.3.1. Biobank Equipment
                            4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.3.1.2. Temperature Control Systems
                                4.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                4.3.1.2.2. Freezers & Refrigerators
                                    4.3.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                4.3.1.2.3. Cryogenic Storage Systems
                                4.3.1.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
                                4.3.1.2.5. Thawing Equipment
                                4.3.1.2.6. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.3.1.3. Incubators & Centrifuges
                                4.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.3.1.4. Alarms & Monitoring Systems
                                4.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.3.1.5. Accessories & Other Equipment
                                4.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.3.2. Biobanking Consumables
                            4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.3.3. Laboratory Information Management Systems
                            4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Biobanks Market: Service Estimates & Trend Analysis
                    5.1. Service Market Share, 2023 & 2030
                    5.2. Global Biobanks Market by Service Outlook
                    5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.3.1. Biobanking & repository
                            5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.2. Lab processing
                            5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.3. Qualification/ Validation
                            5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.4. Cold Chain Logistics
                            5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.5. Other Services
                            5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Biobanks Market: Biospecimen Type Estimates & Trend Analysis
                    6.1. Biospecimen Type Market Share, 2023 & 2030
                    6.2. Global Biobanks Market by Biospecimen Type Outlook
                    6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        6.3.1. Human Tissues
                            6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        6.3.2. Human Organs
                            6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.3.3. Stem Cells
                            6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            6.3.3.2. Adult Stem Cells
                                6.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            6.3.3.3. Embryonic Stem Cells
                                6.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            6.3.3.4. IPS Cells
                                6.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            6.3.3.5. Other Stem Cells
                                6.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.3.4. Other biospecimens
                            6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Biobanks Market: Biobanks Type Estimates & Trend Analysis
                    7.1. Biobanks Type Market Share, 2023 & 2030
                    7.2. Global Biobanks Market by Biobanks Type Outlook
                    7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        7.3.1. Physical/Real biobanks
                            7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                            7.3.1.2. Tissue Biobanks
                                7.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            7.3.1.3. Population based biobanks
                                7.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            7.3.1.4. Genetic (DNA/RNA)
                                7.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            7.3.1.5. Disease based biobanks
                                7.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.2. Virtual biobanks
                            7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Biobanks Market: Ownership Estimates & Trend Analysis
                    8.1. Biobanks Ownership Market Share, 2023 & 2030
                    8.2. Global Biobanks Market by Biobanks Ownership Outlook
                    8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        8.3.1. University Owned
                            8.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        8.3.2. National/Regional Agencies Owned
                            8.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        8.3.3. Non-profit Organization Owned
                            8.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        8.3.4. Private Organization Owned
                            8.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Biobanks Market: Application Estimates & Trend Analysis
                    9.1. Application Market Share, 2023 & 2030
                    9.2. Global Biobanks Market by Application Outlook
                    9.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        9.3.1. Therapeutics
                            9.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        9.3.2. Drug discovery & clinical research
                            9.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        9.3.3. Clinical Diagnostics
                            9.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        9.3.4. Other Applications
                            9.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Biobanks Market: End-use Estimates & Trend Analysis
                    10.1. End-use Market Share, 2023 & 2030
                    10.2. Global Biobanks Market by End-use Outlook
                        10.2.1. Pharmaceutical & Biotechnology Companies
                            10.2.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        10.2.2. CROs & CMOs
                            10.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        10.2.3. Academic & Research Institutes
                            10.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        10.2.4. Hospitals
                            10.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 11. Biobanks Market: Regional Estimates & Trend Analysis
                    11.1. Regional Market Share Analysis, 2023 & 2030
                    11.2. Regional Market Dashboard
                    11.3. Global Regional Market Snapshot
                    11.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    11.5. North America
                        11.5.1. U.S.
                            11.5.1.1. Key country dynamics
                            11.5.1.2. Regulatory framework/ reimbursement structure
                            11.5.1.3. Competitive scenario
                            11.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        11.5.2. Canada
                            11.5.2.1. Key country dynamics
                            11.5.2.2. Regulatory framework/ reimbursement structure
                            11.5.2.3. Competitive scenario
                            11.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                    11.6. Europe
                        11.6.1. UK
                            11.6.1.1. Key country dynamics
                            11.6.1.2. Regulatory framework/ reimbursement structure
                            11.6.1.3. Competitive scenario
                            11.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        11.6.2. Germany
                            11.6.2.1. Key country dynamics
                            11.6.2.2. Regulatory framework/ reimbursement structure
                            11.6.2.3. Competitive scenario
                            11.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        11.6.3. France
                            11.6.3.1. Key country dynamics
                            11.6.3.2. Regulatory framework/ reimbursement structure
                            11.6.3.3. Competitive scenario
                            11.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        11.6.4. Italy
                            11.6.4.1. Key country dynamics
                            11.6.4.2. Regulatory framework/ reimbursement structure
                            11.6.4.3. Competitive scenario
                            11.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        11.6.5. Spain
                            11.6.5.1. Key country dynamics
                            11.6.5.2. Regulatory framework/ reimbursement structure
                            11.6.5.3. Competitive scenario
                            11.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        11.6.6. Norway
                            11.6.6.1. Key country dynamics
                            11.6.6.2. Regulatory framework/ reimbursement structure
                            11.6.6.3. Competitive scenario
                            11.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                        11.6.7. Sweden
                            11.6.7.1. Key country dynamics
                            11.6.7.2. Regulatory framework/ reimbursement structure
                            11.6.7.3. Competitive scenario
                            11.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        11.6.8. Denmark
                            11.6.8.1. Key country dynamics
                            11.6.8.2. Regulatory framework/ reimbursement structure
                            11.6.8.3. Competitive scenario
                            11.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                    11.7. Asia Pacific
                        11.7.1. Japan
                            11.7.1.1. Key country dynamics
                            11.7.1.2. Regulatory framework/ reimbursement structure
                            11.7.1.3. Competitive scenario
                            11.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        11.7.2. China
                            11.7.2.1. Key country dynamics
                            11.7.2.2. Regulatory framework/ reimbursement structure
                            11.7.2.3. Competitive scenario
                            11.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        11.7.3. India
                            11.7.3.1. Key country dynamics
                            11.7.3.2. Regulatory framework/ reimbursement structure
                            11.7.3.3. Competitive scenario
                            11.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        11.7.4. Australia
                            11.7.4.1. Key country dynamics
                            11.7.4.2. Regulatory framework/ reimbursement structure
                            11.7.4.3. Competitive scenario
                            11.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        11.7.5. South Korea
                            11.7.5.1. Key country dynamics
                            11.7.5.2. Regulatory framework/ reimbursement structure
                            11.7.5.3. Competitive scenario
                            11.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        11.7.6. Thailand
                            11.7.6.1. Key country dynamics
                            11.7.6.2. Regulatory framework/ reimbursement structure
                            11.7.6.3. Competitive scenario
                            11.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    11.8. Latin America
                        11.8.1. Brazil
                            11.8.1.1. Key country dynamics
                            11.8.1.2. Regulatory framework/ reimbursement structure
                            11.8.1.3. Competitive scenario
                            11.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        11.8.2. Mexico
                            11.8.2.1. Key country dynamics
                            11.8.2.2. Regulatory framework/ reimbursement structure
                            11.8.2.3. Competitive scenario
                            11.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                        11.8.3. Argentina
                            11.8.3.1. Key country dynamics
                            11.8.3.2. Regulatory framework/ reimbursement structure
                            11.8.3.3. Competitive scenario
                            11.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    11.9. MEA
                        11.9.1. South Africa
                            11.9.1.1. Key country dynamics
                            11.9.1.2. Regulatory framework/ reimbursement structure
                            11.9.1.3. Competitive scenario
                            11.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        11.9.2. Saudi Arabia
                            11.9.2.1. Key country dynamics
                            11.9.2.2. Regulatory framework/ reimbursement structure
                            11.9.2.3. Competitive scenario
                            11.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        11.9.3. UAE
                            11.9.3.1. Key country dynamics
                            11.9.3.2. Regulatory framework/ reimbursement structure
                            11.9.3.3. Competitive scenario
                            11.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        11.9.4. Kuwait
                            11.9.4.1. Key country dynamics
                            11.9.4.2. Regulatory framework/ reimbursement structure
                            11.9.4.3. Competitive scenario
                            11.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 12. Competitive Landscape
                    12.1. Recent Developments & Impact Analysis, By Key Market Participants
                    12.2. Company/Competition Categorization
                    12.3. Vendor Landscape
                        12.3.1. List of key distributors and channel partners
                        12.3.2. Key customers
                        12.3.3. Key company market share analysis, 2023
                        12.3.4. Thermo Fisher Scientific Inc.
                            12.3.4.1. Company overview
                            12.3.4.2. Financial performance
                            12.3.4.3. Product benchmarking
                            12.3.4.4. Strategic initiatives
                        12.3.5. Merck KGaA
                            12.3.5.1. Company overview
                            12.3.5.2. Financial performance
                            12.3.5.3. Product benchmarking
                            12.3.5.4. Strategic initiatives
                        12.3.6. Qiagen
                            12.3.6.1. Company overview
                            12.3.6.2. Financial performance
                            12.3.6.3. Product benchmarking
                            12.3.6.4. Strategic initiatives
                        12.3.7. Hamilton Company
                            12.3.7.1. Company overview
                            12.3.7.2. Financial performance
                            12.3.7.3. Product benchmarking
                            12.3.7.4. Strategic initiatives
                        12.3.8. Tecan Trading AG
                            12.3.8.1. Company overview
                            12.3.8.2. Financial performance
                            12.3.8.3. Product benchmarking
                            12.3.8.4. Strategic initiatives
                        12.3.9. Danaher Corporation
                            12.3.9.1. Company overview
                            12.3.9.2. Financial performance
                            12.3.9.3. Product benchmarking
                            12.3.9.4. Strategic initiatives
                        12.3.10. Becton, Dickinson, and Company (BD)
                            12.3.10.1. Company overview
                            12.3.10.2. Financial performance
                            12.3.10.3. Product benchmarking
                            12.3.10.4. Strategic initiatives
                        12.3.11. Biocision, LLC.
                            12.3.11.1. Company overview
                            12.3.11.2. Financial performance
                            12.3.11.3. Product benchmarking
                            12.3.11.4. Strategic initiatives
                        12.3.12. Taylor-Wharton
                            12.3.12.1. Company overview
                            12.3.12.2. Financial performance
                            12.3.12.3. Product benchmarking
                            12.3.12.4. Strategic initiatives
                        12.3.13. Charles River Laboratories
                            12.3.13.1. Company overview
                            12.3.13.2. Financial performance
                            12.3.13.3. Product benchmarking
                            12.3.13.4. Strategic initiatives
                        12.3.14. Lonza
                            12.3.14.1. Company overview
                            12.3.14.2. Financial performance
                            12.3.14.3. Product benchmarking
                            12.3.14.4. Strategic initiatives
                        12.3.15. Stemcell Technologies
                            12.3.15.1. Company overview
                            12.3.15.2. Financial performance
                            12.3.15.3. Product benchmarking
                            12.3.15.4. Strategic initiatives
                        12.3.16. Biovault Family
                            12.3.16.1. Company overview
                            12.3.16.2. Financial performance
                            12.3.16.3. Product benchmarking
                            12.3.16.4. Strategic initiatives
                        12.3.17. Promocell Gmbh
                            12.3.17.1. Company overview
                            12.3.17.2. Financial performance
                            12.3.17.3. Product benchmarking
                            12.3.17.4. Strategic initiatives
                        12.3.18. Precision Cellular Storage Ltd. (Virgin Health Bank)
                            12.3.18.1. Company overview
                            12.3.18.2. Financial performance
                            12.3.18.3. Product benchmarking
                            12.3.18.4. Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 North America biobanks market, by region, 2018 - 2030 (USD Million)
Table 3 North America biobanks market, by product, 2018 - 2030 (USD Million)
Table 4 North America biobanks market, by service, 2018 - 2030 (USD Million)
Table 5 North America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 6 North America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 7 North America biobanks market, by application, 2018 - 2030 (USD Million)
Table 8 North America biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 9 North America biobanks market, by end-use 2018 - 2030 (USD Million)
Table 10 U.S. biobanks market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. biobanks market, by service, 2018 - 2030 (USD Million)
Table 12 U.S. biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 13 U.S. biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 14 U.S. biobanks market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 16 U.S. biobanks market, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada biobanks market, by product, 2018 - 2030 (USD Million)
Table 18 Canada biobanks market, by service, 2018 - 2030 (USD Million)
Table 19 Canada biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 20 Canada biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 21 Canada biobanks market, by application, 2018 - 2030 (USD Million)
Table 22 Canada biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 23 Canada biobanks market, by end-use, 2018 - 2030 (USD Million)
Table 24 Europe biobanks market, by region, 2018 - 2030 (USD Million)
Table 25 Europe biobanks market, by product, 2018 - 2030 (USD Million)
Table 26 Europe biobanks market, by service, 2018 - 2030 (USD Million)
Table 27 Europe biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 28 Europe biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 29 Europe biobanks market, by application, 2018 - 2030 (USD Million)
Table 30 Europe biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 31 Europe biobanks market, by end-use, 2018 - 2030 (USD Million)
Table 32 Germany biobanks market, by product, 2018 - 2030 (USD Million)
Table 33 Germany biobanks market, by service, 2018 - 2030 (USD Million)
Table 34 Germany biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 35 Germany biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 36 Germany biobanks market, by application, 2018 - 2030 (USD Million)
Table 37 Germany biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 38 Germany biobanks market, by end-use, 2018 - 2030 (USD Million)
Table 39 UK biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 40 UK biobanks market, by end-use, 2018 - 2030 (USD Million)
Table 41 UK biobanks market, by product, 2018 - 2030 (USD Million)
Table 42 UK biobanks market, by service, 2018 - 2030 (USD Million)
Table 43 UK biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 44 UK biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 45 UK biobanks market, by application, 2018 - 2030 (USD Million)
Table 46 UK biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 47 UK biobanks market, by end-use 2018 - 2030 (USD Million)
Table 48 France biobanks market, by product, 2018 - 2030 (USD Million)
Table 49 France biobanks market, by service, 2018 - 2030 (USD Million)
Table 50 France biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 51 France biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 52 France biobanks market, by application, 2018 - 2030 (USD Million)
Table 53 France biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 54 France biobanks market, by end-use 2018 - 2030 (USD Million)
Table 55 Italy biobanks market, by product, 2018 - 2030 (USD Million)
Table 56 Italy biobanks market, by service, 2018 - 2030 (USD Million)
Table 57 Italy biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 58 Italy biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 59 Italy biobanks market, by application, 2018 - 2030 (USD Million)
Table 60 Italy biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 61 Italy biobanks market, by end-use 2018 - 2030 (USD Million)
Table 62 Spain biobanks market, by product, 2018 - 2030 (USD Million)
Table 63 Spain biobanks market, by service, 2018 - 2030 (USD Million)
Table 64 Spain biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 65 Spain biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 66 Spain biobanks market, by application, 2018 - 2030 (USD Million)
Table 67 Spain biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 68 Spain biobanks market, by end-use 2018 - 2030 (USD Million)
Table 69 Denmark biobanks market, by product, 2018 - 2030 (USD Million)
Table 70 Denmark biobanks market, by service, 2018 - 2030 (USD Million)
Table 71 Denmark biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 72 Denmark biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 73 Denmark biobanks market, by application, 2018 - 2030 (USD Million)
Table 74 Denmark biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 75 Denmark biobanks market, by end-use 2018 - 2030 (USD Million)
Table 76 Sweden biobanks market, by product, 2018 - 2030 (USD Million)
Table 77 Sweden biobanks market, by service, 2018 - 2030 (USD Million)
Table 78 Sweden biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 79 Sweden biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 80 Sweden biobanks market, by application, 2018 - 2030 (USD Million)
Table 81 Sweden biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 82 Sweden biobanks market, by end-use 2018 - 2030 (USD Million)
Table 83 Norway biobanks market, by product, 2018 - 2030 (USD Million)
Table 84 Norway biobanks market, by service, 2018 - 2030 (USD Million)
Table 85 Norway biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 86 Norway biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 87 Norway biobanks market, by application, 2018 - 2030 (USD Million)
Table 88 Norway biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 89 Norway biobanks market, by end-use 2018 - 2030 (USD Million)
Table 90 Asia Pacific biobanks market, by region, 2018 - 2030 (USD Million)
Table 91 Asia Pacific biobanks market, by product, 2018 - 2030 (USD Million)
Table 92 Asia Pacific biobanks market, by service, 2018 - 2030 (USD Million)
Table 93 Asia Pacific biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 94 Asia Pacific biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 95 Asia Pacific biobanks market, by application, 2018 - 2030 (USD Million)
Table 96 Asia Pacific biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 97 Asia Pacific biobanks market, by end-use 2018 - 2030 (USD Million)
Table 98 China biobanks market, by product, 2018 - 2030 (USD Million)
Table 99 China biobanks market, by service, 2018 - 2030 (USD Million)
Table 100 China biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 101 China biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 102 China biobanks market, by application, 2018 - 2030 (USD Million)
Table 103 China biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 104 China biobanks market, by end-use 2018 - 2030 (USD Million)
Table 105 Japan biobanks market, by product, 2018 - 2030 (USD Million)
Table 106 Japan biobanks market, by service, 2018 - 2030 (USD Million)
Table 107 Japan biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 108 Japan biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 109 Japan biobanks market, by application, 2018 - 2030 (USD Million)
Table 110 Japan biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 111 Japan biobanks market, by end-use 2018 - 2030 (USD Million)
Table 112 India biobanks market, by product, 2018 - 2030 (USD Million)
Table 113 India biobanks market, by service, 2018 - 2030 (USD Million)
Table 114 India biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 115 India biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 116 India biobanks market, by application, 2018 - 2030 (USD Million)
Table 117 India biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 118 India biobanks market, by end-use 2018 - 2030 (USD Million)
Table 119 South Korea biobanks market, by product, 2018 - 2030 (USD Million)
Table 120 South Korea biobanks market, by service, 2018 - 2030 (USD Million)
Table 121 South Korea biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 122 South Korea biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 123 South Korea biobanks market, by application, 2018 - 2030 (USD Million)
Table 124 South Korea biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 125 South Korea biobanks market, by end-use 2018 - 2030 (USD Million)
Table 126 Australia biobanks market, by product, 2018 - 2030 (USD Million)
Table 127 Australia biobanks market, by service, 2018 - 2030 (USD Million)
Table 128 Australia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 129 Australia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 130 Australia biobanks market, by application, 2018 - 2030 (USD Million)
Table 131 Australia biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 132 Australia biobanks market, by end-use 2018 - 2030 (USD Million)
Table 133 Thailand biobanks market, by product, 2018 - 2030 (USD Million)
Table 134 Thailand biobanks market, by service, 2018 - 2030 (USD Million)
Table 135 Thailand biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 136 Thailand biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 137 Thailand biobanks market, by application, 2018 - 2030 (USD Million)
Table 138 Thailand biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 139 Thailand biobanks market, by end-use 2018 - 2030 (USD Million)
Table 140 Latin America biobanks market, by product, 2018 - 2030 (USD Million)
Table 141 Latin America biobanks market, by service, 2018 - 2030 (USD Million)
Table 142 Latin America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 143 Latin America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 144 Latin America biobanks market, by application, 2018 - 2030 (USD Million)
Table 145 Latin America biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 146 Latin America biobanks market, by end-use 2018 - 2030 (USD Million)
Table 147 Brazil biobanks market, by product, 2018 - 2030 (USD Million)
Table 148 Brazil biobanks market, by service, 2018 - 2030 (USD Million)
Table 149 Brazil biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 150 Brazil biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 151 Brazil biobanks market, by application, 2018 - 2030 (USD Million)
Table 152 Brazil biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 153 Brazil biobanks market, by end-use 2018 - 2030 (USD Million)
Table 154 Mexico biobanks market, by product, 2018 - 2030 (USD Million)
Table 155 Mexico biobanks market, by service, 2018 - 2030 (USD Million)
Table 156 Mexico biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 157 Mexico biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 158 Mexico biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 159 Mexico biobanks market, by end-use 2018 - 2030 (USD Million)
Table 160 Mexico biobanks market, by application, 2018 - 2030 (USD Million)
Table 161 Argentina biobanks market, by product, 2018 - 2030 (USD Million)
Table 162 Argentina biobanks market, by service, 2018 - 2030 (USD Million)
Table 163 Argentina biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 164 Argentina biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 165 Argentina biobanks market, by application, 2018 - 2030 (USD Million)
Table 166 Argentina biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 167 Argentina biobanks market, by end-use 2018 - 2030 (USD Million)
Table 168 MEA biobanks market, by region, 2018 - 2030 (USD Million)
Table 169 MEA biobanks market, by product, 2018 - 2030 (USD Million)
Table 170 MEA biobanks market, by service, 2018 - 2030 (USD Million)
Table 171 MEA biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 172 MEA biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 173 MEA biobanks market, by application, 2018 - 2030 (USD Million)
Table 174 South Africa biobanks market, by product, 2018 - 2030 (USD Million)
Table 175 South Africa biobanks market, by service, 2018 - 2030 (USD Million)
Table 176 South Africa biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 177 South Africa biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 178 South Africa biobanks market, by application, 2018 - 2030 (USD Million)
Table 179 South Africa biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 180 South Africa biobanks market, by end-use 2018 - 2030 (USD Million)
Table 181 Saudi Arabia biobanks market, by product, 2018 - 2030 (USD Million)
Table 182 Saudi Arabia biobanks market, by service, 2018 - 2030 (USD Million)
Table 183 Saudi Arabia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 184 Saudi Arabia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 185 Saudi Arabia biobanks market, by application, 2018 - 2030 (USD Million)
Table 186 Saudi Arabia biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 187 Saudi Arabia biobanks market, by end-use 2018 - 2030 (USD Million)
Table 188 UAE biobanks market, by product, 2018 - 2030 (USD Million)
Table 189 UAE biobanks market, by service, 2018 - 2030 (USD Million)
Table 190 UAE biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 191 UAE biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 192 UAE biobanks market, by application, 2018 - 2030 (USD Million)
Table 193 UAE biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 194 UAE biobanks market, by end-use 2018 - 2030 (USD Million)
Table 195 Kuwait biobanks market, by product, 2018 - 2030 (USD Million)
Table 196 Kuwait biobanks market, by service, 2018 - 2030 (USD Million)
Table 197 Kuwait biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 198 Kuwait biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 199 Kuwait biobanks market, by application, 2018 - 2030 (USD Million)
Table 200 Kuwait biobanks market, by ownership, 2018 - 2030 (USD Million)
Table 201 Kuwait biobanks market, by end-use 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Biobanks market: market outlook
Fig. 14 Biobanks competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Biobanks market driver impact
Fig. 20 Biobanks market restraint impact
Fig. 21 Biobanks market strategic initiatives analysis
Fig. 22 Biobanks market: Product movement analysis
Fig. 23 Biobanks market: Product outlook and key takeaways
Fig. 24 Biobanking equipment market estimates and forecast, 2018 - 2030
Fig. 25 Temperature control systems estimates and forecast, 2018 - 2030
Fig. 26 Freezers & refrigerators market estimates and forecast, 2018 - 2030
Fig. 27 Cryogenic storage systems market estimates and forecast, 2018 - 2030
Fig. 28 Thawing equipment market estimates and forecast, 2018 - 2030
Fig. 29 Incubators & centrifuges market estimates and forecast, 2018 - 2030
Fig. 30 Alarms & monitoring systems market estimates and forecast, 2018 - 2030
Fig. 31 Accessories & other equipment market estimates and forecast, 2018 - 2030
Fig. 32 Biobanking consumables market estimates and forecast, 2018 - 2030
Fig. 33 Laboratory information management systems market estimates and forecast, 2018 - 2030
Fig. 34 Biobanks Market: Service movement Analysis
Fig. 35 Biobanks market: Service outlook and key takeaways
Fig. 36 Biobanking & repository market estimates and forecasts, 2018 - 2030
Fig. 37 Lab processing market estimates and forecasts, 2018 - 2030
Fig. 38 Qualification/ Validation market estimates and forecasts, 2018 - 2030
Fig. 39 Cold chain logistics market estimates and forecasts, 2018 - 2030
Fig. 40 Other services market estimates and forecasts, 2018 - 2030
Fig. 41 Biobanks market: Biospecimen type movement analysis
Fig. 42 Biobanks market: Biospecimen type outlook and key takeaways
Fig. 43 Human tissues market estimates and forecasts, 2018 - 2030
Fig. 44 Human organs market estimates and forecasts, 2018 - 2030
Fig. 45 Stem cells market estimates and forecasts, 2018 - 2030
Fig. 46 Adult stem cells market estimates and forecasts, 2018 - 2030
Fig. 47 Embryonic stem cells market estimates and forecasts, 2018 - 2030
Fig. 48 IPS cells market estimates and forecasts, 2018 - 2030
Fig. 49 Other stem cells market estimates and forecasts, 2018 - 2030
Fig. 50 Other biospecimens market estimates and forecasts, 2018 - 2030
Fig. 51 Biobanks market: Biobanks type movement analysis
Fig. 52 Biobanks market: Biobanks type outlook and key takeaways
Fig. 53 Physical/Real biobanks market estimates and forecasts, 2018 - 2030
Fig. 54 Tissue biobanks market estimates and forecasts, 2018 - 2030
Fig. 55 Population based biobanks market estimates and forecasts, 2018 - 2030
Fig. 56 Genetic (DNA/RNA) market estimates and forecasts, 2018 - 2030
Fig. 57 Disease based biobanks market estimates and forecasts, 2018 - 2030
Fig. 58 Virtual biobanks market estimates and forecasts, 2018 - 2030
Fig. 59 Biobanks market: Application movement analysis
Fig. 60 Biobanks market: Application outlook and key takeaways
Fig. 61 Therapeutics market estimates and forecasts, 2018 - 2030
Fig. 62 Drug discovery & clinical research market estimates and forecasts, 2018 - 2030
Fig. 63 Clinical diagnostics market estimates and forecasts, 2018 - 2030
Fig. 64 Other applications market estimates and forecasts, 2018 - 2030
Fig. 65 Biobanks market: Ownership movement analysis
Fig. 66 Biobanks market: Ownership outlook and key takeaways
Fig. 67 University Owned market estimates and forecasts, 2018 - 2030
Fig. 68 National/regional agencies owned market estimates and forecasts, 2018 - 2030
Fig. 69 NPO owned market estimates and forecasts, 2018 - 2030
Fig. 70 Private organization owned market estimates and forecasts, 2018 - 2030
Fig. 71 Biobanks market: End-use movement analysis
Fig. 72 Biobanks market: End-use outlook and key takeaways
Fig. 73 Pharma & Biotech companies market estimates and forecasts, 2018 - 2030
Fig. 74 CMOs & CROs market estimates and forecasts, 2018 - 2030
Fig. 75 Research & Academic Institutes market estimates and forecasts, 2018 - 2030
Fig. 76 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 77 Global biobanks market: Regional movement analysis
Fig. 78 Global biobanks market: Regional outlook and key takeaways
Fig. 79 Global biobanks market share and leading players
Fig. 80 North America market share and leading players
Fig. 81 Europe market share and leading players
Fig. 82 Asia Pacific market share and leading players
Fig. 83 Latin America market share and leading players
Fig. 84 Middle East & Africa market share and leading players
Fig. 85 North America: SWOT
Fig. 86 Europe SWOT
Fig. 87 Asia Pacific SWOT
Fig. 88 Latin America SWOT
Fig. 89 MEA SWOT
Fig. 90 North America, by country
Fig. 91 North America
Fig. 92 North America market estimates and forecasts, 2018 - 2030
Fig. 93 U.S.
Fig. 94 U.S. market estimates and forecasts, 2018 - 2030
Fig. 95 Canada
Fig. 96 Canada market estimates and forecasts, 2018 - 2030
Fig. 97 Europe
Fig. 98 Europe market estimates and forecasts, 2018 - 2030
Fig. 99 UK
Fig. 100 UK market estimates and forecasts, 2018 - 2030
Fig. 101 Germany
Fig. 102 Germany market estimates and forecasts, 2018 - 2030
Fig. 103 France
Fig. 104 France market estimates and forecasts, 2018 - 2030
Fig. 105 Italy
Fig. 106 Italy market estimates and forecasts, 2018 - 2030
Fig. 107 Spain
Fig. 108 Spain market estimates and forecasts, 2018 - 2030
Fig. 109 Denmark
Fig. 110 Denmark market estimates and forecasts, 2018 - 2030
Fig. 111 Sweden
Fig. 112 Sweden market estimates and forecasts, 2018 - 2030
Fig. 113 Norway
Fig. 114 Norway market estimates and forecasts, 2018 - 2030
Fig. 115 Asia Pacific
Fig. 116 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 117 China
Fig. 118 China market estimates and forecasts, 2018 - 2030
Fig. 119 Japan
Fig. 120 Japan market estimates and forecasts, 2018 - 2030
Fig. 121 India
Fig. 122 India market estimates and forecasts, 2018 - 2030
Fig. 123 Thailand
Fig. 124 Thailand market estimates and forecasts, 2018 - 2030
Fig. 125 South Korea
Fig. 126 South Korea market estimates and forecasts, 2018 - 2030
Fig. 127 Australia
Fig. 128 Australia market estimates and forecasts, 2018 - 2030
Fig. 129 Latin America
Fig. 130 Latin America market estimates and forecasts, 2018 - 2030
Fig. 131 Brazil
Fig. 132 Brazil market estimates and forecasts, 2018 - 2030
Fig. 133 Mexico
Fig. 134 Mexico market estimates and forecasts, 2018 - 2030
Fig. 135 Argentina
Fig. 136 Argentina market estimates and forecasts, 2018 - 2030
Fig. 137 Middle East and Africa
Fig. 138 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 139 South Africa
Fig. 140 South Africa market estimates and forecasts, 2018 - 2030
Fig. 141 Saudi Arabia
Fig. 142 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 143 UAE
Fig. 144 UAE market estimates and forecasts, 2018 - 2030
Fig. 145 Kuwait
Fig. 146 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 147 Market share of key market players- Biobanks market

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Product Outlook (Revenue in USD Million, 2018 - 2030)
    • Biobanking Equipment
      • Temperature Control Systems
        • Freezers & Refrigerators
        • Cryogenic Storage Systems
        • Thawing Equipment
      • Incubators & Centrifuges
      • Alarms & Monitoring Systems
      • Accessories & Other Equipment
    • Biobanking Consumables
    • Laboratory Information Management Systems
  • Service Outlook (Revenue in USD Million, 2018 - 2030)
    • Biobanking & Repository
    • Lab processing
    • Qualification/ Validation
    • Cold Chain Logistics
    • Other Services
  • Biospecimen Type Outlook (Revenue in USD Million; 2018 - 2030)
    • Human Tissues
    • Human Organs
    • Stem Cells
      • Adult Stem Cells
      • Embryonic Stem Cells
      • IPS Cells
      • Other Stem Cells
    • Other Biospecimens
  • Biobanks Type Outlook (Revenue in USD Million; 2018 - 2030)
    • Physical/Real Biobanks
      • Tissue Biobanks
      • Population Based Biobanks
      • Genetic (DNA/RNA)
      • Disease Based Biobanks
    • Virtual Biobanks
  • Application Outlook (Revenue in USD Million; 2018 - 2030)
    • Therapeutics
    • Drug Discovery & Clinical Research
    • Clinical Diagnostics
    • Other Applications
  • Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
    • University Owned
    • National/Regional Agencies Owned
    • Non-profit Organizations Owned
    • Private Organization Owned
  • End-use Outlook (Revenue, USD Billion, 2018 - 2030)
    • Pharmaceutical & Biotechnology Companies
    • CROs & CMOs
    • Academic & Research Institutes
    • Hospitals
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Product Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking Equipment
          • Temperature Control Systems
            • Freezers & Refrigerators
            • Cryogenic Storage Systems
            • Thawing Equipment
          • Incubators & Centrifuges
          • Alarms & Monitoring Systems
          • Accessories & Other Equipment
        • Biobanking Consumables
        • Laboratory Information Management Systems
      • North America Service Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking & Repository
        • Lab processing
        • Qualification/ Validation
        • Cold Chain Logistics
        • Other Services
      • North America Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Human Tissues
        • Human Organs
        • Stem Cells
          • Adult Stem Cells
          • Embryonic Stem Cells
          • IPS Cells
          • Other Stem Cells
        • Other Biospecimens
      • North America Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Physical/Real Biobanks
          • Tissue Biobanks
          • Population Based Biobanks
          • Genetic (DNA/RNA)
          • Disease Based Biobanks
        • Virtual Biobanks
      • North America Application Outlook (Revenue in USD Million, 2018 - 2030)
        • Therapeutics
        • Drug Discovery & Clinical Research
        • Clinical Diagnostics
        • Other Applications
      • North America Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
        • University Owned
        • National/Regional Agencies Owned
        • Non-profit Organizations Owned
        • Private Organization Owned
      • North America End-use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharmaceutical & Biotechnology Companies
        • CROs & CMOs
        • Academic & Research Institutes
        • Hospitals
      • U.S.
        • U.S. Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • U.S. Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • U.S. Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • U.S. Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • U.S. Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • U.S. Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • U.S. End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Canada
        • Canada Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Canada Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Canada Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Canada Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Canada Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Canada Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Canada End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
    • Europe
      • Europe Product Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking Equipment
          • Temperature Control Systems
            • Freezers & Refrigerators
            • Cryogenic Storage Systems
            • Thawing Equipment
          • Incubators & Centrifuges
          • Alarms & Monitoring Systems
          • Accessories & Other Equipment
        • Biobanking Consumables
        • Laboratory Information Management Systems
      • Europe Service Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking & Repository
        • Lab processing
        • Qualification/ Validation
        • Cold Chain Logistics
        • Other Services
      • Europe Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Human Tissues
        • Human Organs
        • Stem Cells
          • Adult Stem Cells
          • Embryonic Stem Cells
          • IPS Cells
          • Other Stem Cells
        • Other Biospecimens
      • Europe Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Physical/Real Biobanks
          • Tissue Biobanks
          • Population Based Biobanks
          • Genetic (DNA/RNA)
          • Disease Based Biobanks
        • Virtual Biobanks
      • Europe Application Outlook (Revenue in USD Million, 2018 - 2030)
        • Therapeutics
        • Drug Discovery & Clinical Research
        • Clinical Diagnostics
        • Other Applications
      • Europe Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
        • University Owned
        • National/Regional Agencies Owned
        • Non-profit Organizations Owned
        • Private Organization Owned
      • Europe America End-use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharmaceutical & Biotechnology Companies
        • CROs & CMOs
        • Academic & Research Institutes
        • Hospitals
      • Germany
        • Germany Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Germany Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Germany Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Germany Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Germany Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • GERMANY Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • GERMANY End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • UK
        • UK Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • UK Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • UK Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • UK Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • UK Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • UK Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • UK End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • France
        • France Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • France Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • France Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • France Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • France Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • France Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • France End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Italy
        • Italy Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Italy Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Italy Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Italy Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Italy Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Italy Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Italy End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Spain
        • Spain Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Spain Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Spain Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Spain Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Spain Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Spain Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Spain End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Denmark
        • Denmark Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Denmark Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Denmark Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Denmark Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Denmark Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Denmark Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Denmark End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Sweden
        • Sweden Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Sweden Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Sweden Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Sweden Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Sweden Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Sweden Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Sweden End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Norway
        • Norway Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Norway Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Norway Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Norway Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Norway Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Norway Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Norway End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
    • Asia Pacific
      • Asia Pacific Product Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking Equipment
          • Temperature Control Systems
            • Freezers & Refrigerators
            • Cryogenic Storage Systems
            • Thawing Equipment
          • Incubators & Centrifuges
          • Alarms & Monitoring Systems
          • Accessories & Other Equipment
        • Biobanking Consumables
        • Laboratory Information Management Systems
      • Asia Pacific Service Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking & Repository
        • Lab processing
        • Qualification/ Validation
        • Cold Chain Logistics
        • Other Services
      • Asia Pacific Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Human Tissues
        • Human Organs
        • Stem Cells
          • Adult Stem Cells
          • Embryonic Stem Cells
          • IPS Cells
          • Other Stem Cells
        • Other Biospecimens
      • Asia Pacific Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Physical/Real Biobanks
          • Tissue Biobanks
          • Population Based Biobanks
          • Genetic (DNA/RNA)
          • Disease Based Biobanks
        • Virtual Biobanks
      • Asia Pacific Application Outlook (Revenue in USD Million, 2018 - 2030)
        • Therapeutics
        • Drug Discovery & Clinical Research
        • Clinical Diagnostics
        • Other Applications
      • Asia Pacific Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
        • University Owned
        • National/Regional Agencies Owned
        • Non-profit Organizations Owned
        • Private Organization Owned
      • Asia Pacific End-use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharmaceutical & Biotechnology Companies
        • CROs & CMOs
        • Academic & Research Institutes
        • Hospitals
      • China
        • China Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • China Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • China Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • China Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • China Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • China Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • China End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Japan
        • Japan Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Japan Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Japan Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Japan Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Japan Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Japan Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Japan End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • India
        • India Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • India Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • India Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • India Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • India Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • India Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • India End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Thailand
        • Thailand Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Thailand Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Thailand Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Thailand Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Thailand Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Thailand Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Thailand End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • South Korea
        • South Korea Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • South Korea Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • South Korea Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • South Korea Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • South Korea Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • South Korea Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • South Korea End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Australia
        • Australia Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Australia Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Australia Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Australia Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Australia Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Australia  Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Australia End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
    • Latin America
      • Latin America Product Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking Equipment
          • Temperature Control Systems
            • Freezers & Refrigerators
            • Cryogenic Storage Systems
            • Thawing Equipment
          • Incubators & Centrifuges
          • Alarms & Monitoring Systems
          • Accessories & Other Equipment
        • Biobanking Consumables
        • Laboratory Information Management Systems
      • Latin America Service Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking & Repository
        • Lab processing
        • Qualification/ Validation
        • Cold Chain Logistics
        • Other Services
      • Latin America Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Human Tissues
        • Human Organs
        • Stem Cells
          • Adult Stem Cells
          • Embryonic Stem Cells
          • IPS Cells
          • Other Stem Cells
        • Other Biospecimens
      • Latin America Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Physical/Real Biobanks
          • Tissue Biobanks
          • Population Based Biobanks
          • Genetic (DNA/RNA)
          • Disease Based Biobanks
        • Virtual Biobanks
      • Latin America Application Outlook (Revenue in USD Million, 2018 - 2030)
        • Therapeutics
        • Drug Discovery & Clinical Research
        • Clinical Diagnostics
        • Other Applications
      • LATAM Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
        • University Owned
        • National/Regional Agencies Owned
        • Non-profit Organizations Owned
        • Private Organization Owned
      • LATAM End-use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharmaceutical & Biotechnology Companies
        • CROs & CMOs
        • Academic & Research Institutes
        • Hospitals
      • Brazil
        • Brazil Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Brazil Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Brazil Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Brazil Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Brazil Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Brazil Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Brazil End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Mexico
        • Mexico Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Mexico Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Mexico Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Mexico Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Mexico Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Mexico Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Mexico End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Argentina
        • Argentina Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Argentina Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Argentina Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Argentina Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Argentina Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Argentina Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Argentina End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
    • Middle East and Africa
      • Middle East and Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking Equipment
          • Temperature Control Systems
            • Freezers & Refrigerators
            • Cryogenic Storage Systems
            • Thawing Equipment
          • Incubators & Centrifuges
          • Alarms & Monitoring Systems
          • Accessories & Other Equipment
        • Biobanking Consumables
        • Laboratory Information Management Systems
      • Middle East and Africa Service Outlook (Revenue in USD Million, 2018 - 2030)
        • Biobanking & Repository
        • Lab processing
        • Qualification/ Validation
        • Cold Chain Logistics
        • Other Services
      • Middle East and Africa Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Human Tissues
        • Human Organs
        • Stem Cells
          • Adult Stem Cells
          • Embryonic Stem Cells
          • IPS Cells
          • Other Stem Cells
        • Other Biospecimens
      • Middle East and Africa Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Physical/Real Biobanks
          • Tissue Biobanks
          • Population Based Biobanks
          • Genetic (DNA/RNA)
          • Disease Based Biobanks
        • Virtual Biobanks
      • Middle East and Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
        • Therapeutics
        • Drug Discovery & Clinical Research
        • Clinical Diagnostics
        • Other Applications
      • MEA Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
        • University Owned
        • National/Regional Agencies Owned
        • Non-profit Organizations Owned
        • Private Organization Owned
      • MEA End-use Outlook (Revenue, USD Billion, 2018 - 2030)
        • Pharmaceutical & Biotechnology Companies
        • CROs & CMOs
        • Academic & Research Institutes
        • Hospitals
      • South Africa
        • South Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • South Africa Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • South Africa Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • South Africa Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • South Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • South Africa Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • South Africa End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Saudi Arabia
        • Saudi Arabia Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Saudi Arabia Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Saudi Arabia Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Saudi Arabia Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Saudi Arabia Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Saudi Arbia  Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Saudi Arabia End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • UAE
        • UAE Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • UAE Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • UAE Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • UAE Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • UAE Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • UAE Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • UAE End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals
      • Kuwait
        • Kuwait Product Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking Equipment
            • Temperature Control Systems
              • Freezers & Refrigerators
              • Cryogenic Storage Systems
              • Thawing Equipment
            • Incubators & Centrifuges
            • Alarms & Monitoring Systems
            • Accessories & Other Equipment
          • Biobanking Consumables
          • Laboratory Information Management Systems
        • Kuwait Service Outlook (Revenue in USD Million, 2018 - 2030)
          • Biobanking & Repository
          • Lab processing
          • Qualification/ Validation
          • Cold Chain Logistics
          • Other Services
        • Kuwait Biospecimen Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Human Tissues
          • Human Organs
          • Stem Cells
            • Adult Stem Cells
            • Embryonic Stem Cells
            • IPS Cells
            • Other Stem Cells
          • Other Biospecimens
        • Kuwait Biobanks Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Physical/Real Biobanks
            • Tissue Biobanks
            • Population Based Biobanks
            • Genetic (DNA/RNA)
            • Disease Based Biobanks
          • Virtual Biobanks
        • Kuwait Application Outlook (Revenue in USD Million, 2018 - 2030)
          • Therapeutics
          • Drug Discovery & Clinical Research
          • Clinical Diagnostics
          • Other Applications
        • Kuwait Biobanks Ownership Outlook (Revenue, USD Billion, 2018 - 2030)
          • University Owned
          • National/Regional Agencies Owned
          • Non-profit Organizations Owned
          • Private Organization Owned
        • Kuwait End-use Outlook (Revenue, USD Billion, 2018 - 2030)
          • Pharmaceutical & Biotechnology Companies
          • CROs & CMOs
          • Academic & Research Institutes
          • Hospitals

Biobanks Market Dynamics

Driver: Role of technology in managing biobanks

Technological advances, especially process automation & computerization, have revolutionized the management of biobanks. Automation is vital in biobanking, where processing, storage, and distribution of samples are involved. Furthermore, the focus on population-based research & precision medicine has increased in North America, Europe, and Asia due to the prevalence of chronic diseases and large geriatric population. These studies involve millions of participants, which leads to large sample collection drives at multiple collection centres with associated clinical & sequence datasets. Large collections are being managed by liquid handling workstations & automated sample storage systems because they reduce the amount of time required to process, store, and distribute samples. The coupling of computerized databases & biobanks with robotics accelerates specimen processing & sampling, which in turn maintains the annotations & locations of specimens. Several software firms are developing packages to support biobanks for applications, such as expenses, consent documentation, tracking inventory, and clinical & laboratory data handling. This continuous digitization & developments in technology will boost the market growth.

Driver: Rising number of clinical trials

The number of clinical trials conducted by companies & research institutes worldwide has increased by threefold since 2010. As of 2021, there were 420,920 clinical studies listed in a database by the U.S. National Library of Medicine. Biobanks globally are storing millions of samples that can be used extensively for clinical & biomedical research. One of the biggest challenges pharmaceutical companies are facing is the rising cost of clinical trials. Biobanks offer biomedical samples that can be used in safety & efficacy studies. Samples of various patients based on demographics can be obtained from biobanks and researched by pharmaceutical companies & research institutes. Biobanks not only provide wide variety of biomedical samples to companies conducting clinical trials but also help reduce the costs associated with clinical trials. This shift to specimen-driven clinical testing is expected to drive the biobank industry.

Restraint: Sustainability challenges

Sustainability concerns are major issues for biobanks globally. Biobanks need well-established processes and are required to be economically stable to continuously provide samples and stay up to date with rapid advances in technology. Moreover, ethical & legal compliance is required for sustained biobanking operations, along with compliance with various changing standardizations & specifications like ISO and CEN/TS for serving a worldwide consumer base. Storage conditions also pose threat to the integrity of the specimens. Conditions like storage temperature, intended duration, the frequency of biospecimen use, purpose, and recovery rate are crucial for biobanking.

What Does This Report Include?

This section will provide insights into the contents included in this biobanks market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Biobanks market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Biobanks market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the biobanks market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for biobanks market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of biobanks market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Biobanks Market Categorization:

The biobanks market was categorized into eight segments, namely product (Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems), service (Biobanking & Repository, Lab Processing, Qualification/ Validation, Cold Chain Logistics), biospecimen type (Human Tissues, Human Organs, Stem Cells), biobanks type (Physical/Real Biobanks, Virtual Biobanks), application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics), ownership (University Owned, National/Regional Agencies Owned, Non-profit Organizations Owned, Private Organization Owned), end-use (Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academic & Research Institutes, Hospitals), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The biobanks market was segmented into product, service, biospecimen type, biobanks type, application, ownership, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The biobanks market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK.; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; and Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Biobanks market companies & financials:

The biobanks market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Thermo Fisher Scientific, Inc. is a global biotechnology company that provides solutions in the diagnostics, life sciences, analytical instruments, and laboratory products market segments. It offers services to various industries, such as biotechnology, pharmaceutical, healthcare, industrial and applied sciences, food and beverage, and forensics, through its brands subsidiary brands. Fisher BioServices is a brand of Thermo Fisher Scientific Inc. that provides biospecimens and biologics management solutions. Its services include biobanking, laboratory processing, kit production, and cold chain logistics. The company recently installed a LiCONiC Semiautomated Biobank (SAB) to manage the utilization demands of samples and offices in various locations including Franklin, MA, Basel, and Switzerland.

  • The Merck Group, known as EMD in the U.S. and Canada, is a global company that operates in the life sciences, healthcare, and electronics markets. The life science business segment operates as MilliporeSigma, a combination of the Millipore corporation and Sigma Aldrich which were acquired in 2010 and 2015, respectively. BioReliance offers pharma and biopharma manufacturing and testing solutions as a CDMO. Sigma-Aldrich Co. LLC operates through three business units: research, SAFC commercials, and applied business, providing over 200,000 products and tools in categories such as analytical, chromatography, spectroscopy, and chemical synthesis.

  • QIAGEN is a key player in the assay technologies market for molecular diagnostics, pharmaceutical, academic, and applied testing. Its product portfolio includes areas of NGS, molecular diagnostics, informatics & data, food & safety testing, oncology, human ID & forensics, and life sciences research. PreAnalytiX GmbH, a joint venture between QIAGEN and Becton, Dickinson and Company (BD), was established in 1999 in Switzerland. The company focuses on the manufacturing and marketing of products for the collection, stabilization, and purification of biospecimens. Its target end users are pharmaceutical and biotech companies, clinical laboratories, academic research organizations, and healthcare institutes.

  • Hamilton Company develops & manufactures sample management systems, automated liquid handling workstations, automated storage solutions, process analytics, and robotics. It also provides laboratory products such as HPLC columns, syringes & needles, pH sensors, OEM solutions, precision measurement devices, and laboratory automation technology for the scientific industry worldwide. Its other headquarters are located in Bonaduz, Switzerland, and Franklin, Massachusetts.

  • Tecan Trading AG offers laboratory instruments and solutions for various applications, such as forensics, clinical diagnostics, genomics, & pharmaceuticals. It develops and commercializes automation and detection products for life sciences laboratories and operates through life sciences, diagnostics, and partnering. It has manufacturing and R&D facilities in North America, Asia, and Europe, and a sales distribution network spanning 70 countries.

  • Danaher Corporation operates in three business segments: diagnostics, life sciences, and environmental & applied solutions. These businesses are unified in their aim to provide products and solutions for disease treatment and research. The diagnostics platform offers reagents, instruments, software, consumables, and services for critical care settings such as hospitals, physician offices, reference laboratories, and others to aid in disease diagnosis and patient management. The life sciences platform provides research tools for scientists to understand disease causes, test new drugs and vaccines, and identify new therapies.

  • BD specializes in microbiology solutions, genomics, drug delivery systems, & infection prevention and possesses 20 brands with various integrated solutions in healthcare. It also offers clinical and research tools, such as monoclonal antibodies, FACS, analyzers, gene expression, and cell culture media through its Biosciences unit, serving biopharmaceutical manufacturers. In addition, it is involved in the development of NGS libraries for research. The company operates globally in over 190 countries, including North America, Latin America, Germany, the Middle East & Africa, and Asia Pacific.

  • BioCision, LLC offers products and solutions for life sciences research, including systems & accessories for temperature stability of biosamples, biomaterials, and temperature-sensitive therapeutics. Its customer base consists of biopharmaceutical companies, academic and governmental institutions, hospitals, & medical device manufacturers for research applications, such as cell cryopreservation, virus cryopreservation, icefree sample freezing & cooling, incubating & thawing, and snap freezing.

  • Taylor-Wharton specializes in cryogenic storage and transport solutions, including regasification equipment, for industries such as life sciences, industrial gas, & LNG. It offers a comprehensive cold chain supply solution and has a global presence with offices in Belgium, Malaysia, Australia, China, Poland, and UAE, covering engineering, production, sales, & distribution.

  • Charles River Laboratories provides preclinical and clinical laboratory services, drug discovery and assessment, and process manufacturing to the pharmaceutical, biotech, and medical device industries. Its portfolio includes biomarkers, cellular therapies, biosimilars, and vaccines, and operates in the segments of Research Models & Services, Discovery & Safety Assessment, and Manufacturing Solutions. It offers R&D outsourcing and testing services and supplies biomedical products, operating in 110 locations across 20 countries. With six key acquisitions since 2020, the company has expanded its cell and gene therapy capabilities.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Biobanks Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2023, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Biobanks Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
Jump to content
pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.